Actuate Therapeutics ACTU Cash Flow Statement (2023-2025)

NASDAQ ACTU
$1.27 +0.04 (+3.25%)
At close: Aug 21, 2026 · 4:00 PM EDT
Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.39M-6.32M-5.95M-5.41M-4.60M
Share-based Compensation (Quarter) 0.07M0.16M0.12M0.15M0.09M0.57M1.19M1.13M1.58M6.02M1.54M
Gains from Investment Securities (Quarter) 0.05M-0.02M0.05M0.03M0.24M-0.19M
Cash from Operations (Quarter) -5.64M-5.51M-5.25M-2.67M-9.15M-4.77M-4.62M-4.17M-6.68M-3.74M
Change in Working Capital
Change in Account Payables (Quarter) 0.22M0.86M0.48M1.93M-3.61M-0.30M0.62M0.51M-1.83M0.19M
Change in Accured Expenses (Quarter) 0.34M0.79M2.77M-3.05M0.89M0.01M0.01M-1.67M1.36M
Investing Activities
Capital Expenditures (Quarter) 0.11M-0.11M
Financing Activities
Other financing activities (Quarter) 23.96M-4.56M-0.03M4.59M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 4.50M1.00M
Change in Capital Stock
Shares Issued (Quarter) 0.27M0.39M0.76M0.78M0.86M1.77M1.80M1.84M
Net Equity Issued and Repurchased (Quarter) 1.66M
Misc.
Cash from Financing Activities (Quarter) 4.36M0.96M22.32M-0.11M-0.13M6.78M17.11M-0.03M
Change in Cash (Quarter) -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M
Free Cash Flow (Quarter) -5.64M-5.51M-5.25M-2.67M-9.15M-4.88M-4.51M-4.17M-6.68M-3.74M
Net Cash Flow (Quarter) -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M